Tumor organoids in cancer medicine: from model systems to natural compound screening
Context The advent of tissue engineering and biomedical techniques has significantly advanced the development of three-dimensional (3D) cell culture systems, particularly tumor organoids. These self-assembled 3D cell clusters closely replicate the histopathological, genetic, and phenotypic character...
Saved in:
Main Authors: | Rong Cong, Can Lu, Xinying Li, Zhijie Xu, Yaqin Wang, Shusen Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Pharmaceutical Biology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/13880209.2025.2458149 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cholangiocyte organoids for disease, cancer, and regenerative medicine
by: Munemasa Nagao, et al.
Published: (2025-03-01) -
Advances, challenges and future applications of liver organoids in experimental regenerative medicine
by: Da Gong, et al.
Published: (2025-01-01) -
Protocol for functional screening of CFTR-targeted genetic therapies in patient-derived organoids using DETECTOR deep-learning-based analysis
by: Mattijs Bulcaen, et al.
Published: (2025-03-01) -
Cost-reduction strategy to culture patient derived bladder tumor organoids
by: Mahsa Mollapour Sisakht, et al.
Published: (2025-02-01) -
Miniaturization and characterization of patient derived hepatocellular carcinoma tumor organoid cultures for cancer drug discovery applications
by: David A. Close, et al.
Published: (2025-01-01)